Suppr超能文献

局部晚期鼻咽癌患者调强放疗后的预后分析

Prognostic analysis of patients with locally advanced nasopharyngeal carcinoma following intensity modulated radiation therapy.

作者信息

Zhao Yajie, Shen Lin, Huang Xinqiong, He Yuxiang, Fu Jun, Qian Yujie, Li Shan, Zhao Na, Shen Liangfang

机构信息

Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.

Department of Hospital Management Consulting Center, National Institute of Hospital Administration, Beijing 100083, P.R. China.

出版信息

Oncol Lett. 2018 Apr;15(4):4445-4450. doi: 10.3892/ol.2018.7850. Epub 2018 Jan 24.

Abstract

The present study retrospectively analyzed the prognostic factors of 135 patients with locally advanced nasopharyngeal carcinoma (NPC) who received intensity modulated radiation therapy between August 2008 and January 2012 at Xiangya Hospital of Central South University. Patients were staged from III-IVA according to the 7th American Joint Committee on Cancer staging system. Using Statistical Analysis System 9.3 software, the present study demonstrated that, among these 135 patients, the 5-year overall survival, the 5-year local relapse-free survival, and the 5-year disease metastasis-free survival were 84, 82, and 78%, respectively. Multivariate Cox regression analysis identified that targeted treatment [hazard ratio (95% confidence interval), 2.642 (1.001, 6.972); P=0.0497] served as an independent negative prognostic factor in locally advanced NPC. The results of immunostaining revealed that the staining intensity of the radiation-resistant group was increased compared with that of the radiation-sensitive group. These results demonstrate that a high expression of EGFR may be associated with radiation resistance, and targeted treatment may not be effective in patients with locally advanced nasopharyngeal carcinoma with low expression of EGFR.

摘要

本研究回顾性分析了2008年8月至2012年1月期间在中南大学湘雅医院接受调强放射治疗的135例局部晚期鼻咽癌(NPC)患者的预后因素。根据美国癌症联合委员会第7版分期系统,患者分期为III-IVA期。使用统计分析系统9.3软件,本研究表明,在这135例患者中,5年总生存率、5年局部无复发生存率和5年无疾病转移生存率分别为84%、82%和78%。多因素Cox回归分析确定,靶向治疗[风险比(95%置信区间),2.642(1.001,6.972);P=0.0497]是局部晚期NPC的独立负性预后因素。免疫染色结果显示,与放射敏感组相比,放射抵抗组的染色强度增加。这些结果表明,EGFR的高表达可能与放射抵抗相关,靶向治疗可能对EGFR低表达的局部晚期鼻咽癌患者无效。

相似文献

本文引用的文献

8
Oncogene mutational profile in nasopharyngeal carcinoma.鼻咽癌中的癌基因突变特征。
Onco Targets Ther. 2014 Mar 20;7:457-67. doi: 10.2147/OTT.S58791. eCollection 2014.
10
Integration of molecular targeted therapy with radiation in head and neck cancer.头颈部肿瘤的分子靶向治疗与放疗的整合。
Pharmacol Ther. 2014 Apr;142(1):88-98. doi: 10.1016/j.pharmthera.2013.11.007. Epub 2013 Nov 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验